Sinopharm Group Co. Ltd Asset Resilience Ratio
Sinopharm Group Co. Ltd asset resilience ratio. Sinopharm Group Co. Ltd (X2S) has an Asset Resilience Ratio of 0.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Sinopharm Group Co. Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sinopharm Group Co. Ltd (2013–2025)
Asset resilience ratio of Sinopharm Group Co. Ltd from 2013 to 2025. This chart shows how Sinopharm Group Co. Ltd's Asset Resilience Ratio has changed over time. Read X2S total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sinopharm Group Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sinopharm Group Co. Ltd assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €129.00K | 0.0% |
| Total Liquid Assets | €129.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Sinopharm Group Co. Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sinopharm Group Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Sinopharm Group Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.04% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
ShareHope Medicine Co Ltd
TWO:8403 |
Medical Distribution | 3.61% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
Sinopharm Group Co. Ltd Asset Resilience Ratio by Year (2013–2025)
Sinopharm Group Co. Ltd asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Sinopharm Group Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.00% | €129.00K ≈ $150.81K |
€390.36 Billion ≈ $456.37 Billion |
0.00pp |
| 2024-12-31 | 0.00% | €158.00K ≈ $184.72K |
€392.83 Billion ≈ $459.26 Billion |
0.00pp |
| 2023-12-31 | 0.00% | €547.00K ≈ $639.50K |
€383.39 Billion ≈ $448.23 Billion |
+0.00pp |
| 2022-12-31 | 0.00% | €498.00K ≈ $582.21K |
€364.78 Billion ≈ $426.46 Billion |
0.00pp |
| 2021-12-31 | 0.00% | €11.75 Million ≈ $13.74 Million |
€335.41 Billion ≈ $392.13 Billion |
-0.01pp |
| 2020-12-31 | 0.01% | €39.14 Million ≈ $45.76 Million |
€311.24 Billion ≈ $363.87 Billion |
+0.01pp |
| 2019-12-31 | 0.00% | €156.00K ≈ $182.38K |
€269.89 Billion ≈ $315.53 Billion |
-0.02pp |
| 2018-12-31 | 0.02% | €41.20 Million ≈ $48.17 Million |
€235.77 Billion ≈ $275.64 Billion |
-0.09pp |
| 2017-12-31 | 0.10% | €175.61 Million ≈ $205.31 Million |
€169.54 Billion ≈ $198.21 Billion |
+0.10pp |
| 2016-12-31 | 0.00% | €5.47 Million ≈ $6.39 Million |
€157.71 Billion ≈ $184.38 Billion |
-0.88pp |
| 2015-12-31 | 0.88% | €1.23 Billion ≈ $1.44 Billion |
€139.43 Billion ≈ $163.01 Billion |
-0.04pp |
| 2014-12-31 | 0.93% | €1.19 Billion ≈ $1.39 Billion |
€128.66 Billion ≈ $150.41 Billion |
+0.10pp |
| 2013-12-31 | 0.83% | €874.07 Million ≈ $1.02 Billion |
€105.45 Billion ≈ $123.29 Billion |
-- |
About Sinopharm Group Co. Ltd
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical … Read more